Whether the effect of rhythm control remains present in patients with diabetes treated with modern antidiabetic drugs (eg, sodium-glucose cotransporter 2 [SGLT2] inhibitors) that improve cardiac metabolism7 and reduce the risk of AF39,40 remains to be tested. Here, SLC5A2 is linked to diabetes mellitus.